Luye Pharma Group Ltd.

04/07/2025 | Press release | Distributed by Public on 04/07/2025 20:23

Luye Pharma’s Class 1 Innovative Antidepressant Ruoxinlin® Approved for Marketing in Macao

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Luye Pharma Group Ltd. published this content on April 07, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 08, 2025 at 02:23 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]